Operating Lease, Right-of-Use Asset of Compass Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Compass Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Compass Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $9,452,000, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Compass Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,452,000 +$2,502,000 +36% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $9,804,000 +$8,651,000 +750% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $6,507,000 +$5,040,000 +344% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $6,731,000 +$4,955,000 +279% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $6,950,000 +$4,867,000 +234% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,153,000 -$1,232,000 -52% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,467,000 -$1,213,000 -45% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,776,000 -$1,191,000 -40% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $2,083,000 -$1,173,000 -36% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $2,385,000 -$1,156,000 -33% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $2,680,000 -$1,139,000 -30% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $2,967,000 -$1,122,000 -27% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $3,256,000 -$1,106,000 -25% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $3,541,000 -$1,089,000 -24% 30 Jun 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 $3,819,000 -$1,073,000 -22% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $4,089,000 +$4,089,000 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $4,362,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $4,630,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $4,892,000 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $0 31 Dec 2020 10-K 18 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.